公司资料
Mersana Therapeutics 股价、新闻与催化剂
- 股票代码:
- MRSN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for MRSN.
公司概览
业务概览
Mersana Therapeutics is an oncology company developing antibody-drug conjugates for cancer. The company’s identity is built around payload delivery and targeted tumor therapy.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Mersana sits in oncology biotechnology.
商业模式特征
Its business depends on clinical data, platform differentiation, and the ability to turn ADC science into a commercial story.
生物医药行业定位
Mersana is a classic ADC catalyst name where efficacy and tolerability can quickly change sentiment.
未来催化剂
- Mersana's catalysts are its ADC programs, especially XMT-1660 and XMT-2056, where any clean data can change the tone quickly. The company is still very much a data story.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。